Epilepsy is one of the most common neurological conditions.<ref>1</ref> For many people, the proper treatment means fewer seizures and a better quality of life. But epilepsy is not “one-size-fits-all”. It often needs careful testing, follow-up, and a team that knows and can handle complex cases.

Epilepsy Germany is a strong option for epilepsy care because the destination combines scale with specialization. More than 400,000 people are estimated to live with epilepsy in the country, which means clinics see a high volume of cases and rare subtypes.<ref>2</ref> In addition, the government also invests heavily in healthcare, with spending around 12.7% of GDP and a well-resourced hospital sector.<ref>3</ref>

In this article, we will walk through the entire journey of epilepsy treatment in Germany. Here, we explore in depth the available treatment options, clinics & doctors, diagnostic specifications, and cost factors. Gathering the facts, we can summarise and answer: why this destination requires attention for patients checking epilepsy treatment abroad, and the exact figures and data that underlie it.

Disease Overview

Epilepsy Seizure Epilepsy is a brain condition that can cause repeated seizures. A seizure is a sudden burst of unusual electrical activity in the brain. Some seizures look dramatic, with shaking and loss of consciousness. Others are subtle. A person may stare, feel confused for a short time, or have strange sensations they cannot explain.<ref>4</ref>

Understanding epilepsy matters because “epilepsy” is a broad label. The World Health Organization (WHO) estimates that around 5 million people are diagnosed with epilepsy each year.<ref>1</ref> There are many seizure types and many epilepsy syndromes. Triggers, risks, and symptoms can vary widely from one person to another.<ref>5</ref> Some people respond well to the first medication they try. Others may need a different drug, a combination of drugs, or a more advanced approach.<ref>6</ref> Epilepsy can also be linked to other health issues, like sleep problems, anxiety, depression, past brain injury, or genetic conditions. These details can change the treatment strategy.<ref>1</ref><ref>7</ref>

If you want a deeper medical explanation of epilepsy, seizure types, diagnostics, and terminology, we cover that in a separate epilepsy disease guide.

Epilepsy Diagnostics in Germany

In Germany, epilepsy diagnostics follow a practical track.<ref>8</ref> The first aim is to confirm that the events are truly epileptic seizures, because several conditions can look similar.<ref>8</ref><ref>9</ref> The second aim is to define the types of seizures and epilepsy, as these directly influence the treatment plan and long-term outlook.

Next, German doctors look for an underlying cause. This step is vital because a structural change in the brain, an inflammation, or a genetic syndrome can require a different strategy than “standard” epilepsy care.<ref>9</ref>

When seizures are difficult to control or when surgery is being discussed, the diagnostic workup becomes more detailed. In these situations, patients are often referred to specialized epilepsy centers, where tests like high-resolution MRI and video-EEG monitoring are used more systematically, in line with established clinical guidance in Germany under epilepsy monitoring unit (EMU).<ref>8</ref><ref>10</ref>

Neurological Exam

Neurological Examination in Germany The primary step is a neurological consultation.<ref>15</ref> It often starts with detailed questions. The doctor will ask what happened before, during, and after the event.<ref>15</ref><ref>16</ref> How the seizures look, their duration, and repetition. They will also ask about sleep, stress, alcohol, medications, and past brain injuries.<ref>17</ref>

A short physical and neurological exam follows. This helps spot “warning signs” that may indicate a structural or systemic problem.<ref>15</ref> Neurological evaluation also helps decide how urgent imaging or inpatient monitoring should be.<ref>18</ref>

Germany has a strong neurology workforce, which supports access to this first-line evaluation. For example, a German medical career overview based on national statistics reports 10,070 practicing neurologists in 2024 (with work split across outpatient and hospital settings).<ref>11</ref>

EEG monitoring

EEG (electroencephalography) records electrical activity in the brain.<ref>19</ref> It is one of the key tests for epilepsy. But it is not perfect, especially if seizures do not happen during the test.<ref>20</ref> A routine EEG in Germany is often the first step and is usually conducted in a short form. It may include “activation” methods like deep breathing, flashing lights, or sleep deprivation.<ref>19</ref>

To help set realistic expectations, patients should understand that a normal EEG does not rule out epilepsy.<ref>15</ref><ref>20</ref> The second clue point is that repeating EEGs improves detection.<ref>21</ref> For instance, in one adult series summarized in a recent review, epileptiform activity was captured in 50% on the first EEG, rising to 84% by the third and 92% by the fourth recording.<ref>12</ref>

For complex cases, Germany uses long-term video-EEG monitoring. This combines continuous EEG with video so that doctors can match symptoms to brain activity. It is widely considered the gold standard for distinguishing between seizure types and non-epileptic events.<ref>22</ref> A German study discussing service models notes that long-term video-EEG is typically inpatient in Germany and available at a limited number of specialized centers with epilepsy monitoring units.<ref>23</ref>

MRI & Advanced Imaging

MRI is the primary imaging test for epilepsy workups, especially when focal seizures are suspected.<ref>25</ref> A high-quality “epilepsy protocol” MRI can reveal lesions that matter for treatment. Examples include scars, malformations of cortical development, tumors, or hippocampal sclerosis.<ref>24</ref>

Germany also has high imaging capacity compared with many countries. Using OECD-based reporting, Germany had 35 MRI units per million people (2021) and about 158 MRI exams per 1,000 people (2021).<ref>13</ref> This supports faster MRI access in many regions, particularly around large hospitals and university centers.

When routine MRI and EEG do not fully explain seizures, specialized centers may add advanced imaging, especially in presurgical diagnostics. Depending on the case, this may include PET, SPECT/SISCOM, functional MRI, or other imaging.<ref>25</ref><ref>26</ref>

In Germany, epilepsy centers use MRI-guided diagnostics with high-resolution “epilepsy protocol” scans (often 3T, sometimes 7T) to detect subtle structural causes such as focal cortical dysplasia or hippocampal sclerosis.<ref>8</ref><ref>39</ref>

To illustrate Germany’s advanced imaging infrastructure, a national PET utilization analysis reported 154,400 PET scans in 2021 (about 1,857 per million inhabitants), with scan volume rising 48% from 2017 to 2021. Neurology accounted for a smaller share of indications (about 4%), but PET remains an essential tool in selected epilepsy evaluations.<ref>14</ref>

Blood Tests & Genetics

Blood tests support epilepsy diagnostics in practical ways. They can help identify potentially reversible seizure triggers (like electrolyte or glucose problems).<ref>27</ref> They also help create safe baselines before starting or adjusting anti-seizure medications, because some drugs require monitoring of liver function, blood counts, or kidney function.<ref>28</ref>

Germany’s epilepsy society (DGfE) has published formal recommendations on genetic diagnostics, reflecting that this has become routine in many appropriate cases.<ref>29</ref> Genetic testing is increasingly important, especially for:

Epilepsy that starts in infancy or childhood;
Developmental delay or intellectual disability;
Syndromic features (other medical findings);
Strong family history;
Drug-resistant epilepsy.

Genetic testing also has a measurable diagnostic yield. The analysis in the Neurology Journal found typical yields of about 23% for epilepsy gene panels and about 32% for whole-exome sequencing (after adjusting for publication bias).<ref>30</ref>

German DGfE’s recommendations also highlight that genetic results can directly affect management, including “precision medicine” decisions for a subset of diagnosed patients (one cited cohort reported that 12% benefited from precision approaches).<ref>31</ref>

Anti-Seizure Medications in Germany

Anti-Seizure Medications in Germany In Germany, anti-seizure medications are the first-line treatment for most people with epilepsy.<ref>40</ref> The national adult guideline states that antiepileptic drugs (AEDs), so-called pharmacotherapy, is the "central pillar." That is why German neurologists usually start with a single drug (monotherapy) and only escalate step by step.<ref>40</ref><ref>8</ref>

Germany's practise notes that many patients become seizure-free with the first medication, and that switching to a second agent brings an additional 10–15% into seizure freedom.<ref>41</ref> When seizures continue after well-chosen trials, treatment planning typically shifts toward a more specialized course.

Epilepsy Medications for Any Scenario

Medication choice in Germany is strongly guided by seizure type and epilepsy type. For new-onset focal epilepsy, the updated German guidance recommends Lamotrigine as first-choice monotherapy, with Lacosamide or Levetiracetam as key alternatives when the first is not suitable.<ref>8</ref>

For genetic generalized epilepsies (especially with myoclonic and tonic-clonic seizures), valproate remains a practical option.<ref>8</ref> However, this is not a clear recommendation, and consulting a German neurologist is the only proper course to get the correct medications.

Follow-up & Practical Aspects

Dose adjustment and follow-up are usually conservative and structured. German doctors typically "start low and go slow," then titrate to the lowest dose that controls seizures with acceptable tolerability.<ref>40</ref>

Side effects are taken seriously because they are common in long-term use.<ref>8</ref> The German policy notes that adverse effects are reported spontaneously by about one-third of patients and are identified in up to two-thirds when structured questionnaires are used.<ref>42</ref> That is why German epilepsy care often includes regular check-ins that focus not only on seizures, but also on mood, sleep, cognition, and day-to-day function.

For international patients paying privately, clinics typically provide a German prescription, and pharmacies dispense the same active substances, sometimes under different brand names.<ref>43</ref>

Germany has clear rules on generic substitution, which matters for epilepsy.<ref>40</ref><ref>43</ref> Certain anti-epileptic medicines and formulations are on the substitution exclusion list, meaning pharmacies must dispense the prescribed product and cannot swap it under "aut-idem" rules.<ref>8</ref>

Drug-resistant Epilepsy Treatment in Germany

In Germany, drug-resistant epilepsy, so-called refractory epilepsy, is not treated as a dead end. It is considered a clear signal to adjust the level of care. The goal shifts from trying “one more” standard adjustment to running a structured review in a specialist setting, so the diagnosis is correct and all proven options are considered early.<ref>44</ref>

Pharmacoresistant Epilepsy Guidelines

Most German pathways follow the international definition used in practice: epilepsy is considered drug-resistant when two appropriately chosen and well-tolerated anti-seizure medication trials (alone or in combination) have failed to achieve sustained long-term seizure freedom.<ref>44</ref>

The current S2k guideline outlining epilepsy treatment for adults in Germany uses a very similar trigger. If two anti-seizure medications (alone or combined) do not achieve seizure freedom over a defined period, this is termed pharmacoresistance.<ref>8</ref> Those patients should be referred to a DGfE-certified specialist outpatient clinic, specialist practice, or epilepsy center to re-evaluate the diagnosis and discuss further options (including surgery or neurostimulation, depending on the case).<ref>32</ref>

German Insights

This escalation matters because the probability of reaching complete seizure freedom with tablets drops sharply once two well-run medication attempts have failed.<ref>45</ref> A German medical news report from the 2025 DGN congress quotes an epilepsy specialist saying that after failure of the second medication, the chance of becoming seizure-free with tablets is only about 1%.<ref>46</ref> Even if the exact percentage varies by patient group, the core message remains the same: waiting too long delays the interventions most likely to help.

German drug-resistant epilepsy treatment is well set up for this step-up model because it has a formal specialist network. As of 3 December 2025, there are 57 DGfE-certified epilepsy centers in Germany.<ref>47</ref> In parallel, the national association also lists certified specialist outpatient services that help patients access expert review without requiring an extended inpatient stay.<ref>48</ref> In practice, this creates a clear “route” from general neurology care to epilepsy-focused teams when seizures remain uncontrolled.

Treatment Strategy

What does refractory epilepsy treatment in Germany look like? It usually starts with a structured validation phase.<ref>49</ref> Specialists re-check whether the events are epileptic seizures or a seizure mimic, whether the epilepsy type has been classified correctly, and whether there are fixable drivers such as missed doses, interacting medications, or an unrecognized secondary disease.<ref>8</ref>

Next comes decision-making, not just testing. Epilepsy centers function as over-regional competence hubs with specialized equipment and expertise for complex epilepsy care.<ref>50</ref> This is where the team can decide, based on a complete picture, whether the best next step is a different medication strategy, a presurgical track, a neurostimulation choice, or supportive therapies that reduce risk and improve daily functioning.<ref>51</ref>

Finally, Germany’s drug-resistant epilepsy care typically includes practical risk management. That means a clear plan for seizure emergencies, injury prevention, driving and work guidance, and coordinated follow-up.<ref>52</ref><ref>53</ref> These steps do not replace seizure control. They reduce harm while the center team works toward the most effective long-term strategy.

Epilepsy Surgery in Germany

Epilepsy operation in Germany is not a niche service. It is a mature, nationwide field with long-term treatment outcome tracking and high presurgical capacity.<ref>51</ref>

In a large German cohort spanning 1990–2013, 3,060 patients underwent presurgical evaluation, and 2,044 ultimately received resective surgery. At the 2-year follow-up, 50.8% were reported to be completely seizure-free.<ref>54</ref>

This makes epilepsy surgery in Germany a wise decision and places the country among the world's leaders.

Resection & Disconnection Surgeries

Resection surgery means removing the seizure-generating tissue when it can be localized and safely accessed.<ref>55</ref> Such a scenario can be a focal epilepsy. In Germany, the most common examples include lesionectomy (removing a visible lesion), temporal lobe surgery (including selective procedures when appropriate), and tailored resections guided by detailed mapping.<ref>56</ref><ref>57</ref> When the epileptic network cannot be safely removed, surgeons may use disconnection strategies to stop seizure spread.<ref>58</ref>

Disconnection procedures are typically considered when seizures arise from broader, eloquent regions or generalized epilepsy.<ref>57</ref> Depending on the patient’s pattern and anatomy, this can include corpus callosotomy (reducing drop attacks by limiting spread between hemispheres) and hemispheric disconnection approaches in carefully selected severe cases.<ref>59</ref><ref>60</ref> These are significant decisions and are usually followed by a full presurgical conference.

Resection & Disconnection Epilepsy Surgeries in Germany

German centers also publish meaningful long-term outcome data. For example, a 10-year follow-up from the Epilepsy Center Berlin-Brandenburg in temporal lobe epilepsy surgery reported that 63% of patients stayed in Engel class I (best outcome), and 48% stayed completely seizure-free (Engel IA) for the full 10 years, 12.5% were never seizure-free, 35% were considered cured (seizure-free without medication).<ref>61</ref>

Implantable Devices

When resection or disconnection is not possible, or when risks are too high, implantable neuromodulation is widely used as a viable tactic during epilepsy surgery in Germany.<ref>8</ref> These therapies aim to reduce seizure frequency and severity rather than remove tissue.<ref>62</ref> They are also used when seizures arise from multiple regions (generalized epilepsy) or from areas that control critical functions.<ref>63</ref>

Implantable Neuromodulation for Epilepsy

Vagus Nerve Stimulation. The most established option is vagus nerve stimulation (VNS).<ref>8</ref> German epilepsy centers have long experience with VNS in real-world care. For instance, one long-term retrospective cohort from the University Hospital Freiburg Epilepsy Center analyzed 62 patients treated with VNS (2002–2011) and documented both treatment outcomes and adverse effects over time.<ref>64</ref>
Deep Brain Stimulation. For deeper modulation of the brain network, Germany also offers anterior thalamic deep brain stimulation (ANT-DBS).<ref>8</ref> European long-term registry data, led by a German epilepsy center (LMU Munich), reported a median reduction in seizure frequency of 56% at 5 years in a subgroup with extended follow-up, and a 41% responder rate at last follow-up in the broader cohort.<ref>65</ref>
Epicranial focal cortex stimulation. Germany is also part of the early clinical rollout for newer focal stimulation concepts. A prominent example is epicranial focal cortex stimulation (FCS) with the EASEE device, where an electrode array is placed above the focus region without opening the skull. In pooled trial results, 33 implanted patients were treated across 6 German sites and 1 Belgian site, showing a median 52% seizure reduction at 6 months and 53.1% of patients responding, with no device- or procedure-related serious adverse events reported.<ref>66</ref>

Minimally Invasive Options

Germany increasingly uses “less invasive” approaches for selected patients, especially when the seizure focus is deep, small, or close to the eloquent cortex.<ref>67</ref> These options aim to reduce recovery time and surgical footprint, but they still require the same high-level presurgical precision.

Minimally Invasive Surgical Options for Epilepsy Treatment in Germany

Laser Interstitial Thermal Therapy. One key approach is Laser Interstitial Thermal Therapy (LITT / LiTT), a stereotactic, image-guided ablation technique. German teams have been active in the field for years, including major academic centers such as Bonn. A German-authored review from the University Clinic Bonn described LiTT as a minimally invasive alternative for some instances. It noted that, at the time, published epilepsy experience was on the order of 200 cases in the literature.<ref>67</ref>
SEEG-Guided Thermocoagulation. Another minimally invasive strategy used in advanced centers is stereotactic techniques that can combine invasive recording with targeted ablation, such as stereoelectroencephalography-guided radiofrequency thermocoagulation.<ref>68</ref> Published national clinical experience shows this is not theoretical. For example, University Hospital Marburg reported 22 patients undergoing SEEG epilepsy surgery in Germany between 2016 and 2024, with 153 depth electrodes implanted.<ref>69</ref>
Radiosurgery. In Germany, a limited number of centers offer stereotactic radiosurgery (Gamma Knife or CyberKnife) for carefully selected drug-resistant epilepsies, most commonly hypothalamic hamartoma, and more rarely mesial temporal lobe epilepsy when open surgery is not suitable.<ref>70</ref><ref>72</ref> The main advantage is an incisionless approach, but seizure improvement can be delayed by months.<ref>71</ref>

Dietary & Metabolic Therapies

In Germany, dietary therapy is used as a medical treatment, not a lifestyle trend. It is most often considered when seizures remain difficult to control with medication, especially in children and adolescents. German guidance also treats it as a first-choice therapy for a small group of rare metabolic conditions where the brain cannot use energy normally.<ref>73</ref>

Ketogenic Dietary Therapy

The main approach is ketogenic dietary therapy (KET), which is a high-fat, low-carbohydrate nutrition plan that keeps the body in ketosis for long periods. The German AWMF S1 guideline names pharmacoresistant or hard-to-treat epilepsies in childhood as key indications.<ref>8</ref> It also states that KET is the therapy of choice for disorders of cerebral energy metabolism, such as GLUT1 deficiency and pyruvate dehydrogenase (PDH) deficiency.<ref>73</ref>

Effectiveness depends on the epilepsy syndrome and how well the diet can be maintained, but the numbers can be impressive in the right patients. A meta-analysis focused on adults with intractable epilepsy reported 13% seizure freedom and 53% achieving at least 50% seizure reduction on ketogenic diet therapy.<ref>74</ref>

In children with drug-resistant epilepsy, the Cochrane review concludes that ketogenic diets can make children up to three times more likely to become seizure-free and up to six times more likely to achieve meaningful seizure reduction compared with usual care.<ref>75</ref> However, results vary across studies and diet variants.

Personalized Approach

Germany uses several practical diet formats, chosen based on age, seizure type, and daily routine. The classic ketogenic diet is the most structured and is often described with ketogenic ratios (for example, 4:1, 3:1, or 2:1).<ref>73</ref>

Germany also uses more flexible variants, such as the Modified Atkins Diet (MAD) and Low Glycemic Index Treatment (LGIT), as well as MCT-based approaches in selected cases. In adult pharmacoresistant epilepsy, German expert guidance highlights MAD as the recommended dietary approach in guidelines and stresses that initiation should happen in a center with ketogenic diet experience.<ref>73</ref>

A key “Germany-specific” point is how these diets are delivered. The AWMF guideline explicitly states that KET must be medically prescribed and requires a treatment team comprising a physician and a nutrition professional, with individualized calculations and routine supplementation of vitamins and minerals.<ref>73</ref>

Metabolic & Vitamin-Dependent Epilepsies

Germany also applies metabolic thinking beyond ketogenic diets. A small but significant subgroup of epilepsies is driven by inborn errors of metabolism or vitamin-dependent mechanisms, where targeted therapy can be decisive.<ref>76</ref> For example, pyridoxine-dependent epilepsy (vitamin B6–responsive epilepsy) is described as very rare, with an often-cited prevalence of around 1 in 100,000.<ref>77</ref>

In infants with severe epilepsy syndromes, metabolic causes are uncommon but clinically meaningful; one recent group of people with infantile epileptic spasms reported inborn errors of metabolism in 5.4% of cases.<ref>78</ref> Therefore, it is one reason German specialist teams may recommend metabolic screening in selected children, rather than only escalating medications.<ref>79</ref>

Why Germany is a Leading Destination

Germany stands out because epilepsy care is organized as a proper system, not a single clinic. There is a dense network of certified centers and outpatient services, and clear pathways for complex cases. The result is that patients can move from first evaluation to advanced decisions without changing countries, languages of care teams, or clinical standards mid-way.

Specialized Epilepsy Centers

The country has an extensive, structured epilepsy infrastructure. The Michael Epilepsy Foundation reports 285 epilepsy-related treatment and counseling offers nationwide. It includes 57 epilepsy centers, 57 specialist epilepsy practices, 97 pediatric epilepsy outpatient clinics, 50 outpatient clinics for adolescents and adults, and 23 counseling centers as of 2026.<ref>32</ref><ref>33</ref>

Within that network, university hospitals play a central role. Several German university centers are also listed in ERN EpiCARE, the European Reference Network for rare and complex epilepsies (Bonn, Erlangen, Freiburg, Tübingen).<ref>34</ref> At the same time, it hosts specialized private providers offering epilepsy treatment in Germany. For example, Schoen Clinic Vogtareuth has access to video-EEG long-term monitoring and, when needed, invasive techniques including stereo-EEG.<ref>80</ref>

Multidisciplinary Epilepsy Team

Epilepsy becomes safer and more treatable when decisions are shared across disciplines. In Germany, this team model is a practical advantage because many epilepsy centers and university departments are built around joint case conferences and shared inpatient units.

Epileptologists

Epileptologists (a neurology subspecialty) focus on seizure classification, medication management, and complex diagnostics. Find the several leading German epeleptologits requring attention:

Epilepsy Neurosurgeons

Neurosurgeons are involved early when seizures remain uncontrolled, and a procedure might help. Check the top neurosurgeons specializing in epilepsy operations:

Neuroradiology

High-quality imaging is central to modern epilepsy care, but its actual value lies in expert interpretation. Explore neuroradiologists with a clear epilepsy focus:

Neuropsychology

Neuropsychology is not optional when advanced treatment is on the table. German patient guidance on epilepsy surgery states that a detailed, often multi-hour neuropsychological assessment should be performed in an epilepsy center before and after epilepsy surgery, because it helps map functions and estimate cognitive risks. German neuropsychologists at a glance:

Genetics

Genetics increasingly changes both diagnosis and treatment planning, especially in early-onset and complex epilepsies. Check what human genetics from Germany might be a good fit:

Research-Driven Approach

Germany’s epilepsy care is tightly linked to structured research and continuous training.<ref>81</ref> The national professional community is large and organized, with the German Epilepsy Society reporting 1,555 members across neurology, neuropediatrics, neurosurgery, research, psychology, and related fields.<ref>82</ref>

There is also substantial, visible investment in epilepsy-related programs. In late 2025, the German Research Foundation (DFG) announced funding for 11 new Research Training Groups totaling €82 million, starting in 2026.<ref>83</ref> One of these groups is focused explicitly on mechanisms that can drive difficult-to-treat epilepsies, aiming to understand focal cortical dysplasias and epileptogenesis and to develop experimental therapeutic approaches.<ref>84</ref>

Research in Germany is strongly “care-connected.” For example, Germany conducts real-world, longitudinal data collection, such as the Mainz Epilepsy Registry (NCT05267405), which follows patients treated at a comprehensive epilepsy and sleep center.<ref>85</ref> Registry data are then used to answer practical questions about outcomes and therapy sequences in routine care, including analyses of published real-world evidence linked to this registry.

Pediatric Epilepsy Expertise

Many childhood epilepsies require more than routine neurology visits. Children often need careful syndrome classification, developmental assessment, and long-term planning that protects learning and psychosocial development.<ref>86</ref>

Pediatric Epilepsy in Germany Germany has a strong pediatric epilepsy capacity, with several centers treating very high volumes and offering genuine “maximal care” for complex cases. For instance, the German Epilepsy Center for Children and Adolescents at Charité is a center for complex and therapy-difficult epilepsies, including emergencies, acute transfers, and second opinions.<ref>87</ref>

Large epilepsy institutions also help in challenging referral scenarios for epilepsy treatment for children in Germany. For example, the Epilepsy Center Bethel reports about 5,000 patients per year from across Europe, spanning children, adolescents, and adults, and it explicitly lists pediatric-inclusive services from diagnostics to surgical therapy and rehabilitation.<ref>88</ref><ref>89</ref>

Measuring German Success in Epilepsy Care

Here, we explore features and facts to confirm that the treatment of epilepsy in Germany has a clear, statistically significant superiority. The data helps patients to make informed decisions when choosing the next care destination.

Domain	What to measure	Evidence
Governance & Standards	National certification structure for epilepsy care sites	DGfE lists certified care structures (specialized practices, ambulatory clinics, centers) and describes certification constructs.<ref>32</ref>
Infrastructure	Certified epilepsy centers	57 DGfE/AG Epilepsy surgery–certified epilepsy centers.<ref>32</ref>
	Certification cycle (quality assurance)	The duration of epilepsy center certification is 5 years.<ref>32</ref>
	Certified adult epilepsy ambulatory clinics	50 DGfE-certified ambulatory clinics for adolescents/adults.<ref>32</ref>
	Certified pediatric epilepsy ambulatory clinics	97 DGfE-certified ambulatory clinics for children/adolescents.<ref>32</ref>
	Specialist outpatient practices	57 specialist epileptology practices.
	Total mapped care	Michael Foundation lists 285 care and counselling services.<ref>33</ref>
Psychosocial care	Epilepsy counseling centers	23 epilepsy counseling centers.<ref>32</ref>
European reference expertise	Membership in ERN EpiCARE	Germany is listed with 4 active EpiCARE centers<ref>34</ref>
Guidelines	National clinical guideline	AWMF S2k guideline “First epileptic seizure and epilepsies in adulthood” is Version 6.0, fully revised 01 Sep 2023, valid until 31 Aug 2028, developed with DGN + DGfE.<ref>8</ref>
Medicines	Antiepileptic drugs (AEDs) prescribing scale	4,115,705 drug prescriptions were analyzed in 2009 for the statutory-insured population (70,011,508 persons).<ref>35</ref>
	Treated epilepsy prevalence	Period prevalence of patients taking AED for epilepsy: 9.1 per 1,000 (children 5.2/1,000; elderly 12.5/1,000).<ref>35</ref>
	Monotherapy rate	68% received AED monotherapy.<ref>35</ref>
	High polytherapy burden	7.9% received >2 AED.<ref>35</ref>
	Annual AED cost burden	AED costs prescribed for epilepsy: €285.1 million; stated as 1% of total medication costs (2009).<ref>35</ref>
Outcomes	Seizure freedom trend	EPIDEG comparison (1995 vs 2010): seizure-free >1 year increased from 60.1% to 70.3%.<ref>36</ref>
	Epilepsy surgery	Reports from the Bonn study: seizure freedom 69-84% at 12 months.<ref>36</ref>
	Tumor-related epilepsy surgery	Seizure freedom up to 75% at 12 months.<ref>36</ref>
Workforce	Neurology involvement	The number of epilepsy patients cared for by neurologists increased from 193,000 to 266,000 (period 1995-2010).<ref>36</ref>
Workforce	National scientific community scale	DGfE 62nd annual meeting held 12–15 Jun 2024; welcome note references >800 expected participants.<ref>37</ref>
Education infrastructure	Long-running EEG/epilepsy skills training	DGfE notice: parallel “EEG Final course” referenced as running since 1989.<ref>38</ref>
Education infrastructure	Dedicated sessions on advanced epilepsy topics	Programs include sessions like “Update Neurostimulation,” “New ways in treatment of status epilepticus,” “Stereo-EEG,” “SUDEP discussion round,” etc.<ref>38</ref>

Best Epilepsy Clinics in Germany

Choosing an epilepsy clinic is less about reputation and more about experience with complex cases and access to complete diagnostics and treatments. Below is a brief overview of the leading epilepsy hospitals in Germany, highlighting what makes them unique and prominent features.

University & Certified Epilepsy Centers

We highlight top-level epilepsy centers within university facilities, combining high academic achievement with innovative daily care.

University Hospital Bonn

The Clinic and Polyclinic for Epileptology at the University Hospital Bonn is positioned as a comprehensive, academically anchored epilepsy center.<ref>90</ref> It combines high-throughput diagnostics with a structured flow for the management of drug-resistant epilepsy. The program is explicitly presented as DGfE-certified and aligned with the German operative epilepsy-therapy community.<ref>91</ref> The team also highlights participation in the European Reference Network for rare and complex epilepsies.<ref>34</ref>

For patients moving beyond first-line antiseizure medication strategies, University Hospital Bonn emphasizes capacity and depth in diagnostic clarification.<ref>91</ref> The hospital reports 12 video-EEG beds for long-term monitoring, routinely complements work-ups with neuropsychology, and offers dietary therapy as an option.<ref>92</ref>

In presurgical evaluation, the clinic provides multimodal imaging (MRI/fMRI, PET/SPECT, SISCOM) and invasive techniques (depth electrodes/cortical stimulation), as well as selected functional testing (e.g., Wada), to support individualized operative planning.<ref>91</ref>

University Hospital Tubingen

University Hospital Tübingen provides epilepsy care as an integrated, multidisciplinary service, anchored in a DGfE-certified epilepsy center.<ref>93</ref> The centre spans children, adolescents, and adults, and is jointly supported by epileptology, neuropediatrics, neurosurgery, and neuroradiology. The scope explicitly includes acute care for seizures, status epilepticus, “epilepsy complex treatment” for severe cases, and surgical options for pharmacoresistant focal epilepsies.<ref>93</ref>

Operationally, University Hospital Tübingen highlights advanced monitoring capability and a tight link between diagnostics and intervention. The clinic has five video-EEG monitoring beds (for differential diagnosis and presurgical assessment), and epilepsy surgery & brain stimulation procedures are delivered in collaboration with neurosurgery.<ref>93</ref>

In parallel, the neurosurgical epilepsy monitoring unit describes a dedicated, fully digital 24-hour video-EEG infrastructure with up to 128 channels and three monitoring beds. The equipment supports high-resolution seizure characterization in both pediatric and adult patients when escalation to surgical evaluation is warranted.<ref>94</ref>

University Hospital Charité Berlin

University Hospital Charité Berlin is a high-volume, university setting for complex epilepsy care. Adult epilepsy outpatient clinics run on all three Charité campuses (Benjamin Franklin, Charité Mitte, Virchow-Klinikum).<ref>95</ref> These DGfE-certified clinics treat over 1,500 patients with epilepsy per year.<ref>96</ref>

Diagnostics are a core strength. Charité’s EEG unit performs approximately 1,800 EEG examinations annually.<ref>97</ref> For inpatient seizure clarification, a department at Campus Virchow-Klinikum has a 12-bed neurology ward with a dedicated video-EEG monitoring unit.<ref>98</ref>

Pediatric epilepsy is a pillar at the hospital. The Neuropediatrics program reports over 10,000 pediatric cases per year (ambulatory and/or inpatient). It offers sleep EEG, surface video-EEG, and, when needed, invasive video-EEG monitoring.<ref>99</ref>

For epilepsy operations, the hospital is integrated into the Berlin–Brandenburg epilepsy surgery program. When surgery is indicated, operations are performed by Charité Neurosurgery at Campus Mitte. University Hospital Charité states that epilepsy surgery here has an average 70% chance of seizure freedom in selected children.<ref>96</ref>

Specialized Private Epilepsy Clinics

Sometimes, the biggest clinics are not the best solution for some patients. For those who require specialized epilepsy services, selected doctors, and better, faster service, private clinics for epilepsy treatment in Germany have what to offer.

Beta Clinic Bonn

Beta Clinic Bonn presents its epilepsy program as a dedicated “Beta International Epilepsy Centre” within its neurology and epileptology department, offering a combined service with a neurosurgery unit.<ref>100</ref>

The clinic has a diagnostic protocol for seizure classification and therapy planning that includes inpatient long-term video-EEG monitoring, advanced neuroimaging (including 3-Tesla MRI). Functional techniques, such as SISCOM, are used alongside it to help localize seizure-onset zones when presurgical clarification is required.<ref>101</ref> For electrophysiology, it explicitly lists routine EEG, long-term EEG, sleep-deprivation EEG, and inpatient video-EEG monitoring as standard modalities for documenting epileptiform activity and correlating clinical events with EEG patterns.<ref>102</ref>

For patients actively exploring escalation options beyond medication, Beta Clinic can offer MRI-guided laser ablation (VISUALASE) as a specialized procedure for selected epilepsy cases.<ref>103</ref> The technique is an uncommon offering in Europe, with a dedicated focus on precision in epilepsy surgery.

Schoen Clinic Vogtareuth

Schön Clinic Vogtareuth is positioned as a highly specialized site for the diagnosis and treatment of epilepsy in Germany across all age groups. The hospital emphasizes detailed imaging and EEG-video monitoring to differentiate epileptic seizures from other paroxysmal disorders and to define surgical candidacy in drug-resistant epilepsy.<ref>104</ref>

In child epilepsy care, the clinic states that presurgical epilepsy diagnostics and epilepsy surgery for children and adolescents have been offered and performed in Vogtareuth since 1999, underlining long-standing operative experience for complex pediatric cases.<ref>105</ref>

For patients explicitly evaluating surgery, Schön Clinic Vogtareuth stresses interdisciplinary planning for epilepsy surgery within its neurosurgical infrastructure and consultation model, aligning diagnostic findings with individualized operative strategies.<ref>105</ref><ref>106</ref>

How to Choose the Right Provider?

Finding the right epilepsy treatment facility in Germany is complex and highly relevant. First, before discussing the specifications and factors of different providers, patients should understand their own medical situation. To summarize the key points, consider your goals: Is it a simple initial diagnosis? Is it a matter of adjusting medication dosage? Should it involve advanced diagnostics followed by individualized drug selection? Are there any surgical procedures that might be appropriate? Or maybe the case is quite advanced, and previous doctors were unable to help, and the process should be started from the beginning? Based on your preliminary inquiries, it makes sense to seek out providers who specialize in your specific situation.

The next step is to gather details about clinics and doctors in Germany. Patients can use Airomedical's clinic search tools or the doctor's sections to find suitable matches. For a more in-depth evaluation, review the profiles of hospitals or doctors, focusing on their credentials, whether epilepsy is their primary focus, and what previous patients have said about their experiences.

Lastly, it is advisable to consider the clinic's location, ensuring it is convenient to travel to, along with any associated costs charged by the selected medical facility.

Epilepsy Treatment Cost in Germany

Knowing the cost of epilepsy treatment in Germany matters. It's no secret that prices can vary a lot. It depends on outpatient vs. inpatient care, the medicines used, and whether more advanced options are included. For some patients, cost is a key decision factor. If you know the expected range in advance, you can prepare better.

Diagnostics Cost

The diagnosis of epilepsy in Germany can have a completely different extent (from a focused outpatient workup to an extensive inpatient program). This depends on the seizure type, how clear the diagnosis is, and whether surgery or device therapy is being considered. Therefore, we listed typical packages and programs that are used in various scenarios.

Name	Setting	Content	Cost
Basic epilepsy diagnostics	Outpatient	Epileptologist intake (history, seizure description, meds), neurological exam, review of prior reports; routine EEG and baseline labs.	From €1,800
Standard epilepsy diagnostics	Outpatient	Epileptologist intake (history, seizure description, meds), neurological exam, review of prior reports; routine EEG; extended laboratory testing; epilepsy-protocol brain MRI.	€4,500–7,200
Extensive epilepsy assessment	Inpatient	Epileptologist intake (history, seizure description, meds), neurological exam, review of prior reports; repeated/extended EEG strategies (24–72h ambulatory or short inpatient); extended laboratory testing; advanced epilepsy imaging: brain MRI/fMRI (3T, thin slices), PET/SPECT; neuropsychological testing; hospitalization for 3-5 days.	From €13,500
Pre-surgical epilepsy evaluation	Inpatient	Epileptologist intake (history, seizure description, meds), neurological exam, review of prior reports; inpatient long-term video-EEG monitoring; extended laboratory testing; advanced epilepsy imaging: brain MRI/fMRI (3T, thin slices), PET/SPECT/SISCOM; neuropsychological testing; multidisciplinary case conference; hospitalization for 5-14 days.	€15,000–45,000
Genetic epilepsy testing	Outpatient	Pre-test counselling, NGS gene panel (with CNV/dup-del where applicable) and/or exome (solo/duo/trio).	From €4,000
Additional blood tests for epilepsy	Outpatient	Targeted testing driven by phenotype: metabolic triggers (glucose, lactate, ammonia), endocrine, toxicology, infection markers, AED drug levels; autoimmune antibody panels.	From €800
Second opinion	Distant	Distant epileptologist intake	From €600

Treatment Cost Ranges

Epilepsy care can range from straightforward outpatient medication management to complex inpatient therapy, depending on seizure control, comorbidities, and whether advanced surgical options are planned. To clarify the cost of epilepsy treatment in Germany, we outline the most common treatment scenarios and procedures used in different clinics.

Name	Setting	Content	Cost
Medical (pharmacologic) monotherapy	Outpatient	Epileptologist antiseizure medication prescription + medication cost.	From €1.000
Medical (pharmacologic) polytherapy	Outpatient	Epileptologist antiseizure medication prescription + several medications costs.	From €1.500
Resective epilepsy surgery	Inpatient	Resection surgery (e.g., temporal lobectomy/lesionectomy/extratemporal resection). Includes neurosurgical admission, surgery cost, OR/anesthesia, intraoperative neurophysiology, standard postoperative imaging/ward care, and early follow-up.	€40,000–90,000
Vagus nerve stimulation	Inpatient	Implantation of pulse generator + vagus nerve lead. Includes neurosurgical admission, surgery cost, VNS device cost, OR/anesthesia, intraoperative neurophysiology, postoperative care, activation, and programming visits.	€20,000–38,000
Deep brain stimulation	Inpatient	DBS system implantation (leads + neurostimulator) with inpatient neurosurgical care plus staged programming.	€60,000–110,000
MR-guided laser interstitial thermal therapy	Inpatient	Minimally invasive stereotactic laser ablation with MRI thermometry guidance (LITT / MRgLITT). Neurosurgical admission, surgery cost, LITT material cost, OR/anesthesia, and postoperative care.	€65,000–120,000
Radiofrequency thermoablation	Inpatient	Stereotactic radiofrequency ablation / thermocoagulation of epileptogenic tissue. Neurosurgical admission, surgery cost, SEEG implantation/monitoring, OR/anesthesia, and postoperative care.	€45,000–70,000
Radiosurgery	Outpatient	Gamma Knife or CyberKnife application. Outpatient admission, pre-procedure re-evaluation, MRI/CT scan, material, neurosurgical, and radiological fees.	€15,000–40,000
Focal cortex stimulation	Inpatient	Includes implantation admission, device cost, doctor's fees, plus repeated outpatient programming/optimization.	€40,000–105,000
Dietary therapy	Outpatient	Structured ketogenic diet therapy delivered by a specialized epilepsy diet team. Dietitian-led planning, ketone monitoring education, and follow-up adjustments with periodic labs.	From €500
Neurorehabilitation	Inpatient/Outpatient	Post-intervention rehabilitation: cognitive, speech, occupational/physiotherapy.	From €16,000

What Can Influence the Price?

Two quotes can look similar on the surface but differ substantially once you compare the included diagnostics, peri-operative care, and the number of follow-up visits. Check what the most fluctuating components of your epilepsy treatment in Germany are.

Provider Factor

The final price in Germany is primarily determined by where the patient is treated and who is providing the care. University hospitals, certified epilepsy centers, and high-volume tertiary programs typically operate with more complex infrastructure and multidisciplinary staffing, which can raise the overall package price compared with smaller providers.

The treating physician’s seniority and subspecialty focus can also influence professional fees and the intensity of follow-up, especially in complex drug-resistant epilepsy pathways.

Medical Program Specs

Equally important is what the quoted “treatment” actually includes. Some offers cover only the core intervention. Others bundle a much broader regimen. This may consist of pre-treatment consultations and a formal anesthesia assessment. It may also include inpatient monitoring. Advanced imaging may be part of the package. Neuropsychological testing is sometimes included.

Many packages also include postoperative imaging. For implantable therapies, the quote may cover device activation. It can also include repeated programming sessions. Finally, some clinics include a defined schedule of structured follow-up appointments.

The duration of hospitalization often has the most significant impact on total cost, particularly for inpatient monitoring, epilepsy surgery, and neuromodulation implantation. If seizures are infrequent, admissions may need to be extended to capture enough events on video-EEG to make a safe treatment decision.

Medical Situation

Clinical complexity is another major driver. A straightforward lesion-positive focal epilepsy case may require fewer diagnostic steps and a shorter inpatient course than MRI-negative or multifocal epilepsy cases with prior brain surgery, significant medical comorbidities, or suspected autoimmune/metabolic etiologies. If invasive techniques are required, such as stereo-EEG or other intracranial recordings to localize the seizure onset zone, costs increase because these pathways add operating room time, specialized consumables, continuous monitoring resources, and typically longer admissions.

Recovery

Postoperative recovery can also vary; an uncomplicated course may be a brief standard-ward stay, while complications or neurological deficits can add extra days, additional imaging, antibiotic therapy, ICU or intermediate-care time, and potentially a subsequent rehabilitation phase.

Medications

Finally, the medication costs can vary widely and are frequently underestimated in long-term planning. Generic antiseizure medications can be relatively inexpensive, whereas newer branded agents, higher doses, or polytherapy regimens can substantially increase annual spending.

FAQ

<faq>Who is a good candidate for epilepsy treatment abroad? Patients with drug-resistant epilepsy, unclear seizure diagnosis despite standard work-up, or those seeking presurgical evaluation, advanced neuromodulation, or a structured second opinion tend to benefit most from treatment abroad.

What treatment flow is typical for epilepsy treatment for adults in Germany compared with pediatric pathways? Adults typically move from optimized antiseizure medication plans to EMU-based video-EEG confirmation and, if drug-resistant focal epilepsy is confirmed, to presurgical evaluation and advanced therapies. Pediatric pathways more often add early syndrome-based work-up (developmental, genetic/metabolic) and may favor earlier escalation because outcomes can affect neurodevelopment.

What makes epilepsy treatment in Germany different from other destinations? Germany has a dense network of DGfE-certified epilepsy services and certified epilepsy centers, which support standardized pathways from diagnostics to epilepsy surgery and long-term follow-up.

How do I choose between a certified epilepsy center in Germany? Start with the DGfE certification category (adult vs pediatric vs epilepsy center) and then match the center’s strengths to your case (EMU capacity, epilepsy surgery program, and experience with your epilepsy type). Use the Airomedical clinic search tool for an advanced selection and check the clinic's profiles for more details.

What documents should international patients prepare? Bring a concise medical summary, seizure diary/video, current and past antiseizure medications (dose, response, adverse effects), and all prior EEG and imaging, especially MRI in DICOM format. Include discharge letters, relevant labs, and any genetics or autoimmune results if already done.

When are VNS and DBS preferred over resective surgery in Germany? They are typically favored when seizures are drug-resistant. Still, a single removable focus cannot be safely defined (multifocal epilepsy, generalized epilepsy, or focus in eloquent cortex), or when resective surgery is declined or has failed. Reviews commonly position VNS/DBS as established options when resection is not feasible.

How is drug-resistant epilepsy defined, and when should you consider escalation beyond antiepileptic drugs (AEDs)? ILAE defines drug-resistant epilepsy as failure of two tolerated, appropriately chosen, and used antiseizure medication schedules (alone or in combination) to achieve long-term seizure freedom. Once that threshold is met, referral for surgical/advanced therapy evaluation is recommended rather than prolonged medication cycling.

What is the difference between focal epilepsy and generalized epilepsy? Focal seizures start in a localized network and may be amenable to focal therapies (resection, ablation, targeted stimulation) if a focus can be defined; generalized seizures engage bilateral networks from onset and are usually managed primarily with systemic therapy and selected neuromodulation. Doctors separate epilepsy types (focal vs. generalized) because this guides diagnostic and therapeutic options.

When is laser interstitial thermal therapy (LITT) considered in Germany? LITT is typically viewed for well-localized drug-resistant focal epilepsy where a minimally invasive ablation could replace or reduce the morbidity of open resection (for example, selected mesial temporal or discrete lesion targets).

What happens during admission to an epilepsy monitoring unit (EMU)? You undergo continuous video-EEG monitoring to capture typical events, confirm diagnosis, classify seizure type, and, when relevant, localize seizure onset for presurgical planning. Admissions commonly last several days and can extend to 1–2 weeks depending on seizure frequency.

What outcomes are typically reported after epilepsy surgery in Germany? Treatment outcomes depend strongly on epilepsy type and localization, but temporal lobe procedures often report seizure-freedom rates around the 60–70% range in selected cohorts. A German university report (FAU/Erlangen) describes 72% seizure freedom at 1 year and 66% at 5 years in its reported series.

What is specific about epilepsy treatment for children in Germany? Pediatric programs generally focus on particular syndromes and integrate neuropediatrics and developmental assessments. They emphasize customized therapies, including medication, dietary interventions, and, when appropriate, epilepsy surgery.

How do German centers coordinate a multidisciplinary epilepsy team? Advanced cases are typically discussed in structured interdisciplinary conferences that combine epileptology, neuroradiology, neuropsychology, and neurosurgery before a definitive therapy decision.

What are realistic timelines from first contact to diagnostics, treatment decision, and intervention in Germany? In typical non-urgent cases, expect 2–6 weeks from first contact to initial specialist assessment, 4–12 weeks to secure an EMU/video-EEG admission, and a treatment decision within 1–2 weeks after diagnostics. The intervention (surgery/ablation/implant) is then usually scheduled 4–12 weeks later, depending on OR and bed availability.

What are the best university hospitals for epilepsy treatment in Germany? University Hospital Bonn, University Hospital Tübingen, and University Hospital Charité Berlin are ranked among the best university-level clinics.

What is the best private clinic for epilepsy treatment in Germany? Beta Clinic Bonn is among the leading private German epilepsy centres.

What responsive neurostimulation options are available in Germany for epilepsy care? The NeuroPace RNS System is described as FDA-approved in the US, and major reviews note RNS for epilepsy as US-only rather than a standard European offering. In Germany, an example of a more “responsive/targeted” neuromodulation alternative is EASEE® (Precisis, Heidelberg).</faq>

References

World Health Organization (WHO). (2024, February 7). Epilepsy. Retrieved December 2025.
Willems, L. M., Hochbaum, M., Zöllner, J. P., Schulz, J., Menzler, K., Langenbruch, L., Kovac, S., Knake, S., von Podewils, F., Hamacher, M., Hamer, H. M., Reese, J.-P., Frey, K., Rosenow, F., & Strzelczyk, A. (2022, April 3). Trends in resource utilization and cost of illness in patients with active epilepsy in Germany from 2003 to 2020. Epilepsia, 63(6), 1591–1602. https://doi.org/10.1111/epi.17229. Retrieved December 2025.
Organisation for Economic Co-operation and Development (OECD). (2023, November 7). Health at a Glance 2023: Germany (Country note). Retrieved December 2025.
Centers for Disease Control and Prevention (CDC). (2024, May 15). Epilepsy Basics. Retrieved December 2025.
International League Against Epilepsy (ILAE). Classification and Definition of Epilepsy Syndromes. Retrieved December 2025.
Centers for Disease Control and Prevention. (2024, May 15). Treatment of epilepsy. Retrieved December 2025.
Tian, N., Wheaton, A. G., Zack, M., Croft, J. B., & Greenlund, K. J. (2021, September). Sleep duration and quality among U.S. adults with epilepsy: National Health Interview Survey 2013, 2015, and 2017. Epilepsy & Behavior, 122, 108194. Retrieved December 2025.
Holtkamp, M., May, T. W., Berkenfeld, R., Bien, C. G., Coban, I., Knake, S., Michaelis, R., Rémi, J., Seeck, M., Surges, R., Weber, Y., et al. (2023, September 1). Erster epileptischer Anfall und Epilepsien im Erwachsenenalter: S2k-Leitlinie. Deutsche Gesellschaft für Neurologie (DGN) in Zusammenarbeit mit der Deutschen Gesellschaft für Epileptologie (DGfE). Retrieved December 2025.
Holtkamp, M., May, T. W., Berkenfeld, R., Bien, C. G., Coban, I., … Zieglgänsberger, D. (2024, March 11). Erster epileptischer Anfall und Epilepsien im Erwachsenenalter. Clinical Epileptology, 37, 118–139. DOI: 10.1007/s10309-024-00663-y. Retrieved December 2025.
Elger, C. E., & Berkenfeld, R. (2017, April 30). Erster epileptischer Anfall und Epilepsien im Erwachsenenalter: S1-Leitlinie. Deutsche Gesellschaft für Neurologie (DGN). Retrieved December 2025.
Hanke, S. (2025, May 30). Facharzt-Weiterbildung Neurologie: Dauer, Inhalte, Berufsperspektiven. ÄRZTESTELLEN. Retrieved December 2025.
Liu, S., Chen, Z., Jiang, J., Liu, Y., … Ando, S. (2025, April 24). Investigating Disparities Between Rural and Urban Epilepsy Patients in Their Risk Factors and Quality of Life: A Review. Neurology International, 17(5), 66. DOI: 10.3390/neurolint17050066. Retrieved December 2025.
World Health Systems Facts. (2025, February 18). Germany: Health System Resources and Utilization. Retrieved December 2025.
Holzgreve, A., Hellwig, D., Barthel, H., Beer, A. J., Kobe, C., Lapa, C., … Fendler, W. P. (2025, May 3). PET imaging utilization and trends in Germany: a comprehensive survey. European Journal of Nuclear Medicine and Molecular Imaging, 52, 4390–4398. https://doi.org/10.1007/s00259-025-07323-x. Retrieved December 2025.
National Institute for Health and Care Excellence (NICE). (2025, January 30). Epilepsies in children, young people and adults. (NICE guideline NG217). Retrieved December 2025.
Epilepsy Society. (2025, December 2). Diagnosing epilepsy. Retrieved December 2025.
Centers for Disease Control and Prevention (CDC). (2024, May 15). Health and Safety Concerns. Retrieved December 2025.
Rowland, K., & Lambert, C. E., Jr. (2022, May). Evaluation After a First Seizure in Adults. American Family Physician, 105(5), 507–513. Retrieved December 2025.
Mesraoua, B., Abou-Khalil, B., Schuknecht, B., Al Hail, H., Ali, M., AbuAlrob, M. A., Zammar, K., & Asadi-Pooya, A. A. (2025, April 24). Epilepsy Diagnosis When the Routine Ancillary Tests Are Normal. Neurology International, 17(5), 66. doi:10.3390/neurolint17050066. Retrieved December 2025.
Sirven, J. I., & Schachter, S. C. (2013, August 22). What if my EEG was normal?. Epilepsy Foundation. Retrieved December 2025.
World Health Organization. (2012). Role of EEG in management of convulsive epilepsy (Q5). Retrieved December 2025.
Tatum, W. O., Mani, J., Jin, K., Halford, J. J., Gloss, D., Fahoum, F., Maillard, L., Mothersill, I., & Beniczky, S. (n.d.). Minimum Standards for Long-term Video-EEG Monitoring. International League Against Epilepsy. Retrieved December 2025.
German Clinical Trials Register. (2025, August 12). Outpatient Long-term Video EEG to Improve Epilepsy Diagnostics (DRKS00032220). Retrieved December 2025.
Bernasconi, A., Cendes, F., Theodore, W. H., Gill, R. S., Koepp, M. J., Hogan, R. E., Jackson, G. D., Federico, P., Labate, A., Vaudano, A. E., Blümcke, I., Ryvlin, P., & Bernasconi, N. (2019). Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force. Epilepsia, 60, 1054–1068. doi:10.1111/epi.15612. Retrieved December 2025.
Traub-Weidinger, T., Arbizu, J., Barthel, H., Boellaard, R., Borgwardt, L., Brendel, M., Cecchin, D., Chassoux, F., Fraioli, F., Garibotto, V., Guedj, E., Hammers, A., Law, I., Morbelli, S., Tolboom, N., Van Weehaeghe, D., Verger, A., Van Paesschen, W., von Oertzen, T. J., Zucchetta, P., & Semah, F. (2024). EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06656-3. Retrieved December 2025.
Biagioli, N., Parfyonov, M., Meletti, S., Pavesi, G., Archer, J., Bernhardt, B. C., … Vaudano, A. E. (2025, March 11). ILAE neuroimaging task force highlight: The utility of multimodal neuroimaging in diagnostic and presurgical workup of drug-resistant focal epilepsy. Epileptic Disorders, 27(3), 439–450. https://doi.org/10.1002/epd2.70016. Retrieved December 2025.
Krumholz, A., Wiebe, S., Gronseth, G., Shinnar, S., Levisohn, P., Ting, T., … French, J. (2007, November 20). Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 69, 1996–2007. https://doi.org/10.1212/01.wnl.0000285084.93652.43. Retrieved December 2025.
Sirven, J. I., & Shafer, P. O. (2013, August 3). Blood Testing for Seizure Medicine. Epilepsy Foundation (Epilepsy.com). Retrieved December 2025.
Boßelmann, C., Borggräfe, I., Fazeli, W., Klein, K.-M., Kluger, G. J., Müller-Schlüter, K., … Krey, I. (2023, April 20). Genetische Diagnostik der Epilepsien: Empfehlung der Kommission Epilepsie und Genetik der Deutschen Gesellschaft für Epileptologie (DGfE). Clinical Epileptology, 36, 224–237. https://doi.org/10.1007/s10309-023-00580-6. Retrieved December 2025.
Sánchez Fernández, I., Loddenkemper, T., Gaínza-Lein, M., Rosen Sheidley, B., & Poduri, A. (2019, January 28). Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study. Neurology, 92(5), e418–e428. https://doi.org/10.1212/WNL.0000000000006850. Retrieved December 2025.
Boßelmann, C., Borggräfe, I., Fazeli, W., Klein, K.-M., Kluger, G. J., Müller-Schlüter, K., Neubauer, B. A., von Spiczak, S., Steinbeis von Stülpnagel, C., Weber, Y., Lemke, J. R., Wolking, S., & Krey, I. (2023, April 20). Genetische Diagnostik der Epilepsien: Empfehlung der Kommission Epilepsie und Genetik der Deutschen Gesellschaft für Epileptologie (DGfE). Clinical Epileptology, 36, 224–237. https://doi.org/10.1007/s10309-023-00580-6. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie (DGfE). (2025, December 22). Behandlungsorte. Retrieved December 2025.
STIFTUNG MICHAEL. Adressen Behandlungs- und Beratungsangebote. Retrieved December 2025.
EpiCARE. List of the ERN EpiCARE centres. Retrieved December 2025.
Hamer, H. M., Dodel, R., Strzelczyk, A., Balzer-Geldsetzer, M., Reese, J.-P., Schöffski, O., Graf, W., Schwab, S., Knake, S., Oertel, W. H., Rosenow, F., & Kostev, K. (2012, April 28). Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany—a nationwide population-based study in children and adults. Journal of Neurology, 259, 2376–2384. https://doi.org/10.1007/s00415-012-6509-3. Retrieved December 2025.
Pfäfflin, M., Stefan, H., & May, T. W. (2020, May 25). Wie viele Patienten mit Epilepsie gibt es in Deutschland, und wer behandelt sie? Vergleich der EPIDEG-Studien 1995 und 2010. Zeitschrift für Epileptologie, 33, 218–225. https://doi.org/10.1007/s10309-020-00334-8. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie e. V. (DGfE). (2024, May 24). DGfE2024: 62. Jahrestagung der Deutschen Gesellschaft für Epileptologie, 12.–15. Juni 2024, Oberrheinhalle Offenburg: Programm. Retrieved December 2025.
Ärzte Zeitung. (2012, September 18). Epilepsiezentrum zertifiziert. Retrieved December 2025.
Universitätsklinikum Erlangen, Neuroradiologie. 7 Tesla Ultrahochfeld MRT. Retrieved December 2025.
Deutsche Hirnstiftung. (2024, October). Leitlinie erster epileptischer Anfall und Epilepsie für Patientinnen und Patienten im Erwachsenenalter (AWMF Registernr. 030/041). Retrieved December 2025.
Hersi, H., Saarinen, J. T., Raitanen, J., & Peltola, J. (2022, November 10). Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.1042168. Retrieved December 2025.
May, T. W. (2013, March). Assessment of adverse effects of antiepileptic drugs. Epileptology, 1(1), 46–54. https://doi.org/10.1016/j.epilep.2013.01.003. Retrieved December 2025.
Bundesministerium für Gesundheit. (2025, November 10). Aut-idem-Regelung. Retrieved December 2025.
Kwan, P., Arzimanoglou, A., Berg, A. T., Brodie, M. J., Hauser, W. A., Mathern, G., … French, J. (2010). Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia, 51(6), 1069–1077. https://doi.org/10.1111/j.1528-1167.2009.02397.x. Retrieved December 2025.
Kwan, P., & Brodie, M. J. (2000, February 3). Early identification of refractory epilepsy. New England Journal of Medicine, 342(5), 314–319. https://doi.org/10.1056/NEJM200002033420503. Retrieved December 2025.
Deutsches Ärzteblatt. (2025, November 27). „Eine Therapieresistenz bei Epilepsie wird in Deutschland viel zu spät festgestellt“. Retrieved December 2025.
Stiftung Michael. (2025, December 3). Adressen Behandlungs- und Beratungsangebote. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie (DGfE). Ambulanzen. Retrieved December 2025.
Singh, R., Chakravarty, K., Baishya, J., Goyal, M. K., & Kharbanda, P. (2020, June 1). Management of Refractory Epilepsy. International Journal of Epilepsy, 6(1), 15–23. https://doi.org/10.1055/s-0040-1712837. Retrieved December 2025.
Universitätsklinikum Gießen und Marburg (UKGM). Video-EEG-Monitoring und prächirurgische Diagnostik. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie (DGfE). Epilepsiechirurgie. Retrieved December 2025.
Deutsche Epilepsievereinigung e.V. (2025, April 24). Erste Hilfe. Retrieved December 2025.
Deutsche Gesetzliche Unfallversicherung e.V. (DGUV). (2019, December). Berufliche Beurteilung bei Epilepsie und nach erstem epileptischen Anfall (DGUV Information 250-001; aktualisierte Fassung). Retrieved December 2025.
Cloppenborg, T., May, T. W., Blümcke, I., Grewe, P., Hopf, L. J., Kalbhenn, T., Pfäfflin, M., Polster, T., Schulz, R., Woermann, F. G., & Bien, C. G. (2016, December). Trends in epilepsy surgery: stable surgical numbers despite increasing presurgical volumes. Journal of Neurology, Neurosurgery & Psychiatry, 87(12), 1322–1329. https://doi.org/10.1136/jnnp-2016-313831. Retrieved December 2025.
Universitätsklinikum Bonn. Epilepsiechirurgie. Retrieved December 2025.
Uniklinik RWTH Aachen. Epilepsiechirurgie. Retrieved December 2025.
Universitätsklinikum Erlangen. Epilepsiechirurgie. Retrieved December 2025.
CURE Epilepsy. Epilepsy Surgery. Retrieved December 2025.
Kim, J.-S., Park, E.-K., Shim, K.-W., Kim, D. S., et al. (2018, June 30). Hemispherotomy and Functional Hemispherectomy: Indications and Outcomes. Journal of Epilepsy Research, 8(1), 1–5. https://doi.org/10.14581/jer.18001. Retrieved December 2025.
UCSF Health. Disconnection Procedures. UCSF Health. Retrieved December 2025.
Schmitt, F. C., & Meencke, H.-J. (2020, January 7). Factors predicting 10-year seizure freedom after temporal lobe resection: A monocentric, continuous extra-long-term evaluation. Zeitschrift für Epileptologie, 33, 50–61. https://doi.org/10.1007/s10309-019-00302-x. Retrieved December 2025.
Deutsche Epilepsievereinigung e.V. (2024, November 22). Neurostimulation in der Epilepsiebehandlung. Deutsche Epilepsievereinigung e.V. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie (DGfE). (2024, May 13). Neurostimulation in der Epilepsiebehandlung. DGfE – Informationspool Epilepsie. Retrieved December 2025.
Carius, A., & Wintermantel, A. (2013, November 10). Vagusnervstimulationstherapie bei Epilepsiepatienten: Langzeitoutcome und Nebenwirkungen: eine retrospektive Analyse. Der Nervenarzt, 84, 1473–1485. https://doi.org/10.1007/s00115-013-3923-4. Retrieved December 2025.
Kaufmann, E., et al. (2024). Long-term evaluation of anterior thalamic deep brain stimulation for epilepsy in the European MORE registry. Epilepsia. Retrieved December 2025.
JAMA Neurology. (2023). Focal Cortex Stimulation With a Novel Implantable Device and Antiseizure Outcomes in 2 Prospective Multicenter Single-Arm Trials. JAMA Network. Retrieved December 2025.
Prince, E., Hakimian, S., Ko, A. L., Ojemann, J. G., Kim, M. S., … Miller, J. W. (2017, July 11). Laser Interstitial Thermal Therapy for Epilepsy. Current Neurology and Neuroscience Reports, 17, Article 63. https://doi.org/10.1007/s11910-017-0772-8. Retrieved December 2025.
Bourdillon, P., et al. (2018). SEEG-guided radiofrequency thermocoagulation. Neurochirurgie (ScienceDirect). Retrieved December 2025.
El Mahi, O., Marini, C., Møller, R. S., Navarro, V., Iqbal, D., Auvin, S., Krammer, F. J., Thivard, L., Matricardi, S., Pradier, B., Vallée, L., Lamhauge, A. S., Nabbout, R., & De Maria, G. (2025). New Frontiers in Autoimmune Epilepsy: A Network Meta-Analysis of Clinical and Biomarker Outcomes. Brain Sciences, 15(2), 184. https://doi.org/10.3390/brainsci15020184. Retrieved December 2025.
Quigg, M., & Barbaro, N. M. (2008, February). Stereotactic Radiosurgery for Treatment of Epilepsy. Archives of Neurology, 65(2), 177–183. https://doi.org/10.1001/archneurol.2007.40. Retrieved December 2025.
Şen, A., Capraz, I., & Uluc, K. (2012, June). Hypothalamic hamartoma in paediatric patients. Neurología (English Edition), 27(4), 231–238. https://doi.org/10.1016/j.nrleng.2011.10.004. Retrieved December 2025.
Romanelli, P., Muacevic, A., & Striano, S. (2008). Radiosurgery for hypothalamic hamartomas. Neurosurgical Focus, 24(5), E9. https://doi.org/10.3171/FOC/2008/24/5/E9. Retrieved December 2025.
Gesellschaft für Neuropädiatrie. (2022, February). Ketogene Ernährungstherapien (KET). AWMF-Leitlinien-Register Nr. 022/021 (Entwicklungsstufe 1). Retrieved December 2025.
Liu, H., Yang, Y., Wang, Y., Tang, H., Zhang, F., Zhang, Y., & Zhao, Y. (2018). Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies. Epilepsia Open, 3(1), 9–17. https://doi.org/10.1002/epi4.12098. Retrieved December 2025.
Cochrane. Ketogenic diets for drug-resistant epilepsy. Retrieved December 2025.
van Karnebeek, C. D. M., Sayson, B., Lee, J. J. Y., Tseng, L. A., Blau, N., Horvath, G. A., & Ferreira, C. R. (2018, December 3). Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions. Frontiers in Neurology, 9, 1016. https://doi.org/10.3389/fneur.2018.01016. Retrieved December 2025.
MedlinePlus Genetics. (2013, February 1). Pyridoxine-dependent epilepsy. Retrieved December 2025.
Yüksel, M. F., Doğulu, N., Yıldırım, M., Köse, E., Bektaş, Ö., Eminoğlu, F. T., & Teber, S. (2024, March 16). Metabolic etiologies in children with infantile epileptic spasm syndrome: Experience at a tertiary pediatric neurology center. Brain and Development, 46(6), 213–218. https://doi.org/10.1016/j.braindev.2024.03.003. Retrieved December 2025.
Neubauer, B. A., & Hahn, A. (2018, March). Diagnostische Prinzipien bei Epilepsien des Kindesalters (S1-Leitlinie 022-007). Retrieved December 2025.
Schön Klinik Vogtareuth. Epilepsie – Kinder und Jugendliche: Behandlung. Retrieved December 2025.
International League Against Epilepsy (ILAE). German Chapter report 2021–2022. Retrieved December 2025.
Deutsche Gesellschaft für Epileptologie (DGfE). Über Uns: Dt. Gesellschaft für Epileptologie – Informationspool Epilepsie. Retrieved December 2025.
Deutsche Forschungsgemeinschaft (DFG). (2025, November 27). DFG fördert elf neue Graduiertenkollegs. Retrieved December 2025.
University of Bonn. (2025, November 27). University of Bonn to Host New Research Training Group. Retrieved December 2025.
ClinicalTrials.gov. Mainz Epilepsy Registry (NCT05267405). Retrieved December 2025.
Waltz, S., Borusiak, P., Hoffmann, I., Schliermann, T., Schwartzenberger, K., & Wegener, A. (2007, March 1). Epilepsien: Diagnostik und Therapie im SPZ. Deutsche Gesellschaft für Sozialpädiatrie und Jugendmedizin (DGSPJ). Retrieved December 2025.
Charité – Universitätsmedizin Berlin. Deutsches Epilepsiezentrum für Kinder und Jugendliche an der Charité. Retrieved December 2025.
Evangelisches Klinikum Bethel (EvKB). Epilepsie-Zentrum Bethel. Retrieved December 2025.
Krankenhaus Mara. Bethel – Universitätsklinik für Epileptologie. Retrieved December 2025.
Universitätsklinikum Bonn (UKB). Klinik und Poliklinik für Epileptologie. Retrieved December 2025.
Universitätsklinikum Bonn (UKB). Department of Epileptology. Retrieved December 2025.
Universitätsklinikum Bonn (UKB). Informationen für Patientinnen und Patienten. Retrieved December 2025.
Hertie-Institut für klinische Hirnforschung (HIH). Neurologie mit Schwerpunkt Epileptologie: Über uns. Retrieved December 2025.
Universitätsklinikum Tübingen. Video-EEG-Monitoring in der Epilepsie-Monitoringeinheit. Retrieved December 2025.
Epilepsie-Zentrum Berlin-Brandenburg (EZBB). Epilepsy outpatient clinic for adults. Retrieved December 2025.
Charité – Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller Neurologie. Epilepsien und andere Anfallserkrankungen. Retrieved December 2025.
Charité – Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller Neurologie. EEG (Elektroenzephalografie). Retrieved December 2025.
Charité – Universitätsmedizin Berlin, Klinik für Neurologie mit Experimenteller Neurologie. Ward 7a – General Neurology. Retrieved December 2025.
Charité – Universitätsmedizin Berlin. Deutsches Epilepsiezentrum für Kinder und Jugendliche. Retrieved December 2025.
Beta Klinik Bonn. Neurology and Epilepsy. Retrieved December 2025.
Beta Klinik Bonn. Epilepsy. Retrieved December 2025.
Beta Klinik Bonn. Electrophysiology neurology and epileptology. Retrieved December 2025.
Beta Klinik Bonn. Therapy. Retrieved December 2025.
Schön Klinik Vogtareuth. Epilepsie – unsere Behandlung. Retrieved December 2025.
Schön Klinik Vogtareuth. Epilepsie bei Kindern und Jugendlichen – unsere Behandlung. Retrieved December 2025.
Schoen Clinic Vogtareuth. Schoen Clinic Vogtareuth. Retrieved December 2025.

</reflinks>